{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001486","form_type":"8-K","ticker":"ACBM","cik":"0001622996","company_name":"ACRO BIOMEDICAL CO., LTD.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.506761+00:00","generated_at":"2026-05-17T13:13:25.097098+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns","bullets":["Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.","Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.","Ms. Su previously served as VP of cell banking division at BioSpring Co., Ltd. (Jan 2023 - Aug 2025) and VP at BioSeed Co., Ltd. (Aug 2020 - Dec 2022)."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001486","json":"https://secwatch.observer/filing/0001640334-25-001486.json","markdown":"https://secwatch.observer/filing/0001640334-25-001486.md","text":"https://secwatch.observer/filing/0001640334-25-001486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/0001640334-25-001486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/acbm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:13:25.097098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}